Watch SK Conversations: Parents’ Playbook for Pediatric Pain Management

As a parent and advocate for your child’s health, your most valuable tool is knowledge. Equipping yourself with the right information can make a world of difference for your child as they recover from routine events like getting their wisdom teeth removed, or unexpected injuries that necessitate surgery.

Watch the recap of SK Conversations: Parents’ Playbook for Pediatric Pain Management where our panel of medical experts shared how to navigate your child’s recovery plan. We explored today’s leading non-opioid pain management options and how to prioritize your child’s safety while effectively managing pain. You will walk away with invaluable advice on how to be your child’s best advocate.

The Experts

Dr. Stone and Dr. Sethi are consultants of Pacira BioSciences, Inc.

Dr. Mona Stone

Dr. Mona Stone is not only an esteemed oral and maxillofacial surgeon practicing full-scope surgery, but she is also a public speaker, activist, philanthropist, and the co-founder of the grassroots organization Real Heroes Need Masks.

After receiving her dental degree from the University of Missouri-Kansas City, she went on to do a year of internship at Truman Medical Center and then a residency in Oral and Maxillofacial Surgery at Broward General Medical Center.

Dr. Stone practices the full scope of the specialty, including maxillofacial pathology, dentoalveolar surgery, implant surgery, maxillofacial reconstruction, microvascular surgery, facial cosmetic surgery, and trauma surgery. She is also an attending surgeon at Baylor Medical Center Grapevine, Irving, and at Methodist Hospital.

Dr. Paul Sethi

Dr. Paul Sethi is a board-certified orthopedic surgeon specializing in sports medicine conditions of the elbow, knee, and shoulder. He is a leading research physician who speaks at academic and instructional medical conferences in the U.S. and abroad. His research on surgical advances in his specialty is regularly published in leading medical journals, including the Journal for Shoulder and Elbow Surgery, Arthroscopy, and the Journal of the American Academy for Orthopedic Surgery.

He also collaborates with outside companies for education and research purposes and to develop medical procedures on the shoulder, elbow, and knee. Dr. Sethi is a member of the prestigious American Shoulder and Elbow Society and the American Academy of Orthopedic Surgeons. He also serves as President of the ONS Foundation for Clinical Research and Education (ONSF).

For more information on EXPAREL, please visit www.EXPAREL.com/safety. 

Indication

EXPAREL^® (bupivacaine liposome injectable suspension) is indicated for single-dose infiltration in patients aged 6 years and older to produce postsurgical local analgesia and in adults as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia. Safety and efficacy have not been established in other nerve blocks.

Important Safety Information

EXPAREL should not be used in obstetrical paracervical block anesthesia.

In studies in adults where EXPAREL was injected into a wound, the most common side effects were nausea, constipation, and vomiting.

In studies in adults where EXPAREL was injected near a nerve, the most common side effects were nausea, fever, and constipation.

In the study where EXPAREL was given to children, the most common side effects were nausea, vomiting, constipation, low blood pressure, low number of red blood cells, muscle twitching, blurred vision, itching, and rapid heartbeat.

EXPAREL can cause a temporary loss of feeling and/or loss of muscle movement. How much and how long the loss of feeling and/or muscle movement depends on where and how much of EXPAREL was injected and may last for up to 5 days.

EXPAREL is not recommended to be used in patients younger than 6 years old for injection into the wound, for patients younger than 18 years old for injection near a nerve, and/or in pregnant women.

Tell your healthcare provider if you or your child has liver disease, since this may affect how the active ingredient (bupivacaine) in EXPAREL is eliminated from the body.

EXPAREL should not be injected into the spine, joints, or veins.

The active ingredient in EXPAREL can affect the nervous system and the cardiovascular system; may cause an allergic reaction; may cause damage if injected into the joints; and can cause a rare blood disorder.

FOR MORE INFORMATION, PLEASE VISIT www.EXPAREL.com or CALL 1-855-793-9727. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-108